Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing.

Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing.

<h4>Background</h4>Snakebite is a major public health concern in Eswatini, where treatment relies upon one antivenom-SAIMR Polyvalent. Although effective in treating snakebite, SAIMR Polyvalent is difficult to source outside its manufacturing country (South Africa) and is dauntingly expe...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefanie K Menzies, Thea Litschka-Koen, Rebecca J Edge, Jaffer Alsolaiss, Edouard Crittenden, Steven R Hall, Adam Westhorpe, Brent Thomas, James Murray, Nondusimo Shongwe, Sara Padidar, David G Lalloo, Nicholas R Casewell, Jonathan Pons, Robert A Harrison
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-09-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0010496&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0010496&type=printable

Similar Items